跳至主要内容
临床试验/NCT06845332
NCT06845332招募中不适用

PROTeCt-NEO: Promoting Optimal Treatment Choices Through Implementation of Antibiotic Stewardship Strategies in Neonates With Suspected Early-Onset Sepsis

Franciscus Gasthuis11 个研究点 分布在 1 个国家目标入组 55,000 人开始时间: 2024年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
55,000
试验地点
11
主要终点
Days on therapy

研究概览

简要总结

In this study, three neonatal evidence-based antibiotic stewardship strategies will be implemented in Dutch hospitals. These include the early-onset sepsis (EOS) calculator, procalcitonin (PCT)-guided therapy, and IV-to-oral switch therapy. These strategies have been proven to be effective and safe and are already applied in several Dutch hospitals. However, this is not the case for all hospitals, leading to significant variations in clinical practice. To facilitate the translation of evidence into practice, active implementation will take place.

The primary research design is a prospective implementation study, using a multicenter, non-randomized pre-post design. The aim is to assess the impact of implementing a bundle of antibiotic stewardship interventions (including the EOS calculator, PCT-guided therapy and iv-to-oral switch therapy) in Dutch hospitals, using a multicomponent implementation strategy, on both clinical and implementation outcomes, with a particular focus on evaluating the employed implementation strategies.

A combination of qualitative and quantitative research methods will be used to assess outcomes. Quantitative clinical data from neonates in the pre- and post-implementation periods will be retrospectively collected by the Business Intelligence units of participating hospitals and anonymized before being provided to the central research team. Qualitative data will be gathered through focus groups, interviews, and surveys.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Other

入排标准

年龄范围
— 至 3 Days(Child)
性别
All
接受健康志愿者
否

入选标准

  • •Neonates born at 34 weeks of gestation or later
  • •0-3 days old

排除标准

  • •stillborn neonates

结局指标

主要结局

Days on therapy

时间窗: 12 months pre-implementation and 12 months post-implementation

次要结局

未报告次要终点

研究者

发起方
Franciscus Gasthuis
申办方类型
Other
责任方
Sponsor

研究点 (11)

Loading locations...

相似试验